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Abstract Plasmids containing the origin of replication, oriP, of
the Epstein-Barr virus (EBV) and EBV nuclear antigen-1 genes
replicate extrachromosomally in primate cells. However, these
plasmids have been believed not to replicate in rodent cells. We
demonstrate here that these plasmids can replicate in some types
of rodent cells over a long period. This result should offer not
only the new insight into the mechanisms of species-specific
replication of EBV, but also the possibility that an EBV-based
vector can be used for gene transfer experiments in non-primate
cells and an animal experiment regarding human gene therapy.
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1. Introduction
Episomal vectors which replicate extrachromosomally in
cells over a long period are useful tools for studying the ex-
pression of cloned genes and gene therapy [1]. Epstein-Barr
virus (EBV)-derived plasmid is one of the promising candi-
dates for use in these types of studies [2^4]. The viral elements
required for episomal replication and nuclear retention are the
cis-acting replication origin (oriP) of the EBV gene and the
EBV nuclear antigen-1 (EBNA-1), which interacts with the
oriP region [2^4]. Plasmids containing the oriP and EBNA-1
sequences are maintained as low-copy number DNA episomes
in the cell nucleus and replicate once per cell cycle in primate
cells [5].
OriP is composed of two clusters of the EBNA-1 binding
region: a family of repeat and a dyad symmetry sequence
[3,6]. Both elements have multiple binding sites for EBNA-1,
and are essential for replication and nuclear retention of the
plasmid containing oriP [7]. The dyad symmetry sequence is
important in the initiation of DNA replication [8,9], while the
family of repeat acts as an EBNA-1-dependent enhancer and
is responsible for DNA replication and for the stable segre-
gation of the viral episome [3,10,11]. Host cellular factors
assist the replication and nuclear retention of the plasmid
containing both the oriP and the EBNA-1 sequences [12].
Several previous reports have demonstrated that the long-
term replication of EBV-derived plasmid occurs in primate
cells but not in rodent cells [2,13]. In rodent cells, EBV-de-
rived plasmid seems to have only the nuclear retention func-
tion and the enhancer activity of transgene expression induced
by EBNA-1 [14^16]. Speci¢c factors derived from primate
cells have been believed to be required for long-term replica-
tion and maintenance of EBV-derived plasmid.
In this study, we demonstrate that plasmids containing the
oriP and EBNA-1 sequences can replicate in some kinds of
rodent cells. Long-term replication of EBV-derived plasmid in
their cell lines was shown by colony formation assay, sus-
tained transgene expression and Southern blot analysis using
the di¡erence of methylation of input DNA and replicated
DNA in the mammalian cells.
2. Materials and methods
2.1. Plasmid
An EBV-derived plasmid, pREP10-L1, contains the oriP and the
EBNA-1 gene which is derived from pREP10 (Invitrogen, Carlsbad,
CA, USA), the hygromycin-resistant gene, and the luciferase gene
which is driven by the Rous sarcoma virus long terminal repeat
(RSV-LTR) promoter (Fig. 1A). The EBNA-1 gene in pREP10-L1
codes the truncated protein (the deletion of GlyAla repeat domain).
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Fig. 1. The plasmid structure. (A) pREP10-L1, (B) pHRSVL.
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pHRSVL contains the luciferase gene driven by the RSV-LTR pro-
moter and hygromycin-resistant gene, but does not contain oriP or
the EBNA-1 gene (Fig. 1B).
2.2. Cells
HeLa cells (from human epitheloid carcinoma of the cervix, ob-
tained from Dr. M.A. Kay, Stanford University, USA), RL-34 cells
(from rat liver epithelial cells, Human Science Research Resources
Bank (HSRRB), Japan, JCRB0247) and L6 cells (from rat skeletal
muscle myoblast; HSRRB, JCRB9081) were cultured with Dulbecco’s
modi¢ed Eagle’s medium supplemented with 10% fetal calf serum
(FCS). L cells (Lcl1D, from mouse skin ¢broblast; HSRRB,
JCRB0722) and NIH3T3 cells (from mouse embryo ¢broblast;
HSRRB, JCRB0615) were cultured with minimum essential medium
(MEM) supplemented with 10% FCS. BHK-21 cells (from hamster
kidney; HSRRB, JCRB9020) were cultured with MEM supplemented
with 10% FCS and non-essential amino acids. Chinese hamster ovary
(CHO) cells (obtained from Dr. T. Mayumi, Osaka University, Japan)
were cultured with MEM alpha medium supplemented with 10% FCS.
C6 cells (from rat glioma; HSRRB, JCRB9096) were cultured with
Ham’s F10 medium supplemented with 10% FCS. In the colony for-
mation assay, the cells were selected with the following concentrations
of hygromycin B (Wg/ml): BHK-21 and NIH3T3, 60; HeLa, 200; C6
and RL-34, 350; CHO and L6, 500; L, 600.
Fig. 2. E⁄ciency of colony formation of various cell lines transfected by pREP10-L1 or pHRSVL. HeLa (A, B), L (C, D), L6 (E, F) and C6
(G, H) cells were transfected by pREP10-L1 (A, C, E, G) or pHRSVL (B, D, F, H) using Superfect. On the following day, the cells were pas-
saged and cultured with medium containing hygromycin B. After 12^14 days of culture, the cell colonies were stained with crystal-violet.
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2.3. Colony formation assay
The cells (1U105 cells) were seeded into 12-well dishes. On the
following day, pREP10-L1 or pHRSVL (1.5 Wg) were transfected
with Superfect (Qiagen) for 2 h according to the manufacturer’s in-
structions. The DNA amount was corrected using the plasmid pUC18
to transfect equal molars of pREP10-L1 and pHRSVL. 24 h later, the
cells were detached and suspended with fresh medium (¢nal volume,
10.0 ml), and 5.0 ml of the cell suspension was seeded into a 60 mm
dish. The following day, the medium was changed to that containing
hygromycin B. After 12^14 days in culture, the cell colonies were
stained with crystal-violet.
2.4. Luciferase assay
pREP10-L1 or pHRSVL (1.0 Wg) were transfected into the cells
(5U104 cells) according to the same protocol as that used in the
colony formation assay. After 2, 4, 6 and 8 days in culture with
normal medium without hygromycin B, luciferase activity in the cells
was measured using a luciferase assay system (PicaGene LT2.0, Toyo
Inki Co. Ltd., Tokyo, Japan). We repeated all transfection experi-
ments, including the colony formation assay, and obtained similar
results.
2.5. Southern blot analysis
Hygromycin B-resistant cell colonies (HeLa, L6, C6 and L) trans-
fected by pREP10-L1 were grown as pools. After 2 months in culture,
low molecular weight DNA was prepared as described by Hirt [18].
Hirt supernatant DNA was digested by XbaI (single cutter), XbaI/
MboI or XbaI/DpnI, electrophoresed on 0.7% agarose gels, and trans-
ferred to a Hybond nylon ¢lter (Amersham, Buckinghamshire, UK).
The blots were hybridized using [K-32P]dCTP-labelled DNA probes
(BamHI/NotI fragment (hygromycin gene) of pREP10-L1).
3. Results
3.1. Colony formation of hygromycin-resistant cells transfected
by EBV-based vector
When the colony formation assay in the cell lines (most of
human origin) transfected by EBV-derived plasmids (i.e.
pREP10-L1) (Fig. 1) was performed, we found that mouse
L cells transfected by EBV-derived plasmid had a much great-
er number of hygromycin-resistant colonies than did those
transfected by pHRSVL, which contained the luciferase ex-
pression cassette and the hygromycin B-resistant gene, but not
oriP or EBNA-1 gene. This ¢nding led us to speculate that
some kinds of rodent cells can support the long-term replica-
tion of EBV-based plasmid, although it has not been believed
that EBV-based plasmid replicates in rodent cells [2,13].
Therefore, we examined the long-term replication of EBV-
based plasmid in various kinds of rodent cells by using colony
formation assay.
Mouse (L, NIH3T3), rat (L6, C6, RL-34), hamster (CHO,
BHK-21) and human (HeLa)-derived cells were transfected by
pREP10-L1 or pHRSVL, and the number of hygromycin-re-
sistant colonies was compared (Fig. 2). HeLa, L and L6 cells
transfected by pREP10-L1 had about 500, 1000 and 30 times
more colonies than those transfected by pHRSVL, respec-
tively. C6 cells transfected by pREP10-L1 showed a number
of colonies, while the cells transfected by pHRSVL showed
none in the condition of this study. In contrast, in NIH3T3,
RL-34, CHO and BHK-21 cells, the colony numbers were
similar between pREP10-L1 and pHRSVL (data not shown).
The hygromycin B-resistant colony transfected by pHRSVL
should re£ect the integration of the plasmid (hygromycin-re-
sistant gene) into the genomic chromosomes of the cells. Thus,
the larger number of resistant colonies in pREP10-L1-trans-
fected cells might account for the long-term episomal replica-
tion of the plasmid outside the chromosome. pREP4-L1,
which has the EBNA-1 gene containing the GlyAla repeat
domain derived from pREP4 (Invitrogen), also showed similar
results with pREP10-L1, which contains the truncated EBNA-
1 gene (data not shown).
3.2. Southern blot analysis of episomal replication of
EBV-based vector
To examine the episomal replication of pREP10-L1 in
HeLa, L, L6 and C6 cells, low molecular weight DNAs
were isolated by Hirt’s method [17] from the hygromycin B-
resistant cells. Hirt DNAs were then digested by XbaI (one
cutter), XbaI/MboI or XbaI/DpnI, electrophoresed and sub-
jected to Southern blotting. MboI cut the DNA which had
lost the bacterial methylation, while DpnI cut the methylated
DNA. Therefore, input DNA, which was prepared from Es-
cherichia coli, is susceptible to DpnI (but not to MboI), while
the DNA which had been replicated in the mammalian cells is
susceptible to MboI (but not to DpnI).
As seen in Fig. 3, Hirt DNAs from HeLa, L6 and C6 cells
were digested by MboI, but not by DpnI. In contrast,
pREP10-L1 prepared with E. coli was digested by DpnI, but
not by MboI, which showed the opposite pattern as that of
Hirt DNA. These results suggest that pREP10-L1 did repli-
cate in the rodent cells (L6 and C6 cells) as well as in the
primate cells (HeLa cells) over a long period. In spite of con-
siderable e¡orts, we could not detect any signals in Southern
blotting using both Hirt DNA and whole genomic DNA re-
covered from pREP10-L1-transfected L cells, both of which
were resistant to hygromycin B and expressed luciferase.
However, taking into consideration the Southern blotting of
pREP10-L1-transfected L6 and C6 cells and the colony for-
mation assay shown in Fig. 2, L cells might also support the
long-term replication of pREP10-L1.
3.3. Prolonged and enhanced luciferase expression by
EBV-based vector
Next, we examined whether pREP10-L1 causes more pro-
longed and enhanced luciferase expression in rodent cells than
does pHRSVL due to the retention [18,19], replication [2,4]
Fig. 3. Replication analysis of pREP10-L1 in various cell lines. Hirt
supernatant DNAs were prepared from HeLa (lanes 4^6), L6 (lanes
7^9) and C6 (lanes 10^12) cells transfected by pREP10-L1. Each
cell was cultured for 2 months. DNA was digested by XbaI (single
cutter) (lanes 1, 4, 7, 10), XbaI/MboI (lanes 2, 5, 8, 11) or XbaI/
DpnI (lanes 3, 6, 9, 12). As a control, plasmid pREP10-L1, which
was prepared with E. coli, was also analyzed (lanes 1^3). Hygromy-
cin gene was used as a DNA probe.
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and enhancing activity [10,11] induced by the EBV-derived
fragment (Fig. 4). All cell lines transfected by pREP10-L1
showed higher luciferase expression than those transfected
by pHRSVL. In HeLa, L, L6 and C6 cells, which supported
the long-term replication of pREP10-L1, prolonged luciferase
expression was also observed by the transfection of pREP10-
L1 (Fig. 4A^D). In contrast, in 3T3, CHO, BHK-21 and RL-
34 cells, longer duration of luciferase expression was not ob-
served (Fig. 4E^H). These results suggested that the EBV-
derived fragment up-regulated transcription of the RSV pro-
moter-driven luciferase gene in all cell lines examined, and
that in some cell lines, prolonged luciferase expression was
also observed due to the replication activity of pREP10-L1.
In this study, we saw no evidence of retention activity of
pREP10-L1 in the cell lines which did not support the repli-
cation of pREP10-L1.
4. Discussion
In this paper, we demonstrated that the plasmid containing
the oriP and EBNA-1 genes did replicate e⁄ciently in some
kinds of rodent cells as well as in human (primate) cells. Yates
et al. developed an EBV-derived episomal vector and showed
that the vector replicates in primate cells, but not in rodent
cells [2]. Since then, rodent cells have been believed to be non-
permissive for the replication of the EBV-derived vector [13].
Therefore, host cellular factor(s) derived from primate cells
have been believed to cooperate with EBNA-1 to mediate
plasmid replication. However, only limited kinds of rodent
cells have been analyzed in terms of plasmid replication so
far. We analyzed the long-term replication of EBV-derived
plasmid in seven kinds of rodent cells. Among them, three
kinds of cells (L, L6, C6) supported the long-term replication
of EBV-derived plasmid e⁄ciently (Figs. 2 and 3).
Only two reports have described the successful use of EBV-
derived vectors in rodent cells, rat C6 glioma cells [15] and rat
pheochromocytoma PC12 cells [20], although these studies did
not analyze the use of these vectors in great depth. In con-
trast, one report described that even human-derived cells (HT-
1376 bladder carcinoma cells) did not support the replication
of EBV-derived plasmid [21]. These results, combined with
our present data, suggest that other factor(s) might play
more important roles in the long-term replication of EBV-
derived plasmid in cells than might species-speci¢c factor(s).
EBV-derived plasmid, pREP10-L1, also showed higher lu-
ciferase expression in both human and rodent cells than did
the plasmid without the EBV fragment, pHRSVL (Fig. 4).
This is consistent with previous reports [14^16]. The EBNA-
1^oriP system has several functions other than plasmid repli-
cation, such as the nuclear retention of the plasmid containing
oriP [18,19], and the transactivation of EBV transcriptional
enhancer by EBNA-1 [10,11]. These functions would enhance
the induction of luciferase expression by pREP10-L1,
although the retention activity of pREP10-L1 was not con-
¢rmed in 3T3, CHO, BHK-21 or RL-34 cells.
Several research groups developed EBV-derived vectors
which contain large fragments of human genomic DNA as
well as the EBNA-1 gene and the family of repeat sequence
[1,13,22^26]. Such vectors were reported to replicate in rodent
cells [13,22]. Calos and colleagues showed that hamster BHK
cells support the long-term replication of modi¢ed EBV-based
vectors carrying large fragments of human DNA, but not that
of the wild-type EBV-based vector [13]. Although we demon-
strated that EBV-based vectors could replicate in some kinds
of rodent cells, the modi¢cation of the vector described by
Calos et al. would broaden the tropism of the EBV-based
episomal vector.
One of the problems of EBV-based vectors in regard to
their application in gene therapy is that there is no small
animal model which supports the replication of the vector.
Recently, prolonged and enhanced transgene expression in
mice liver and muscle transduced by the EBV-based vectors
has been reported [16,27]. Plasmid replication might have
played a role in these phenomena, although the authors dis-
cussed that sustained gene expression was only due to nuclear
retention and not the replication of the vector.
In summary, ours is the ¢rst report to clearly demonstrate
that EBV-derived plasmid replicates in rodent cells as well as
in primate cells. Taken together with the long-term replication
and enhanced transgene expression induced by EBV-based
vectors in the rodent cells, this vector, combined with non-
viral gene transfer vectors such as cationic lipids [28] and
fusogenic liposomes based on Sendai virus [29,30], should
constitute a useful tool for human gene therapy as well as
provide on experimental model for gene therapy using small
animals and for gene transfer experiments in non-primate
cells. In addition, this study o¡ers new insight into the mech-
anisms of the species-speci¢c replication of EBV.
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